Trial Details

COMPLETED
Basic Information
Clinical ID c1338
Identifier NCT00676832
Trial Title Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Placebo|DRUG: COLAL-PRED
Participant Information
Sponsor Prometheus Laboratories
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-05-08
Primary Completion Date 2025-10-09
Completion Date 2025-10-09